SEARCH

SEARCH BY CITATION

REFERENCES

  • Abi-Dargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J. 1997. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci 9: 117.
  • Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263265.
  • Bortolato M, Chen K, Shih JC. 2008. Monoamine oxidase inactivation: From pathophysiology to therapeutics. Adv Drug Deliv Rev 60: 15271533.
  • Cardno AG, Gottesman II. 2000. Twin studies of schizophrenia: From bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97: 1217.
  • Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, Maffei P, Franke P, Fritze J, et al. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8: 621624.
  • Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66: 8798.
  • Gauderman WJ. 2002. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155: 478484.
  • Geyer MA, Vollenweider FX. 2008. Serotonin research: Contributions to understanding psychoses. Trends Pharmacol Sci 29: 445453.
  • Guo G, Ou XM, Roettger M, Shih JC. 2008. The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood: Associations and MAOA promoter activity. Eur J Hum Genet 16: 626634.
  • Handoko HY, Nyholt DR, Hayward NK, Nertney DA, Hannah DE, Windus LC, McCormack CM, Smith HJ, Filippich C, James MR, et al. 2005. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol Psychiatry 10: 589597.
  • Hotamisligil GS, Breakefield XO. 1991. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49: 383392.
  • Huang SY, Lin WW, Wan FJ, Chang AJ, Ko HC, Wang TJ, Wu PL, Lu RB. 2007. Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci 32: 185192.
  • Huang SY, Lin MT, Lin WW, Huang CC, Shy MJ, Lu RB. 2009. Association of monoamine oxidase A (MAOA) polymorphisms and clinical subgroups of major depressive disorders in the Han Chinese population. World J Biol Psychiatry 10: 544551.
  • Jahng JW, Houpt TA, Wessel TC, Chen K, Shih JC, Joh TH. 1997. Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization. Synapse 25: 3036.
  • Jonsson EG, Norton N, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Owen MJ, Sedvall GC. 2003. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr Res 61: 3137.
  • Kang SG, Park YM, Choi JE, Lim SW, Lee HJ, Lee SH, Kim YK, Kim SH, Cho SN, Kim L. 2010. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. Hum Psychopharmacol 25: 397403.
  • Lan NC, Heinzmann C, Gal A, Klisak I, Orth U, Lai E, Grimsby J, Sparkes RS, Mohandas T, Shih JC. 1989. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease. Genomics 4: 552559.
  • Li D, He L. 2008. Meta-study on association between the monoamine oxidase A gene (MAOA) and schizophrenia. Am J Med Genet Part B 147B: 174178.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402408.
  • Meltzer HY. 1989. Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 99 Suppl: S18S27.
  • Meltzer HY. 2002. Commentary on “clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (1989) 99:S18–S27. Psychopharmacology (Berl) 163: 13.
  • Mossner R, Henneberg A, Schmitt A, Syagailo YV, Grassle M, Hennig T, Simantov R, Gerlach M, Riederer P, Lesch KP. 2001. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry 6: 350352.
  • Nagatsu T. 2004. Progress in monoamine oxidase (MAO) research in relation to genetic engineering. Neurotoxicology 25: 1120.
  • Nakamura Y, Koyama K, Matsushima M. 1998. VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J Hum Genet 43: 149152.
  • Pickard BS, Christoforou A, Thomson PA, Fawkes A, Evans KL, Morris SW, Porteous DJ, Blackwood DH, Muir WJ. 2009. Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder. Mol Psychiatry 14: 874884.
  • Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15: 293297.
  • Qiu HT, Meng HQ, Song C, Xiu MH, Chen da C, Zhu FY, Wu GY, Kosten TA, Kosten TR, Zhang XY. 2009. Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population. Brain Res 1287: 6773.
  • Sabol SZ, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103: 273279.
  • Salokangas RK, Honkonen T, Saarinen S. 2003. Women have later onset than men in schizophrenia–but only in its paranoid form. Results of the DSP project. Eur Psychiatry 18: 274281.
  • Shi YZ, Wang CH, Lv LX, Wang YH, Zhang HX, Lou BY. 2007. [Association study of the polymorphisms of monoamine oxidase A genes with schizophrenia]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24: 457459.
  • Sullivan PF, Kendler KS, Neale MC. 2003. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60: 11871192.
  • Syagailo YV, Stober G, Grassle M, Reimer E, Knapp M, Jungkunz G, Okladnova O, Meyer J, Lesch KP. 2001. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. Am J Med Genet 105: 168171.
  • Tadic A, Rujescu D, Szegedi A, Giegling I, Singer P, Moller HJ, Dahmen N. 2003. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet Part B 117B: 16.
  • Westlund KN, Denney RM, Rose RM, Abell CW. 1988. Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neuroscience 25: 439456.
  • Xu Q, Jia YB, Zhang BY, Zou K, Tao YB, Wang YP, Qiang BQ, Wu GY, Shen Y, Ji HK, et al. 2004. Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: A novel strategy for complex disorders. Mol Psychiatry 9: 510521.
  • Zhang J, Chen Y, Zhang K, Yang H, Sun Y, Fang Y, Shen Y, Xu Q. 2010. A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder. Biol Psychiatry 68: 795800.